366785-16-2

Upstream product

• 366785-14-0 (4S,5R)-4-(N,N-dibenzylamino)-1-(tert-butyldimethylsilyloxy)-5-[(2-methoxyethoxy)methoxy]heptadecane 
• 366785-12-8 (4S)-4-(N,N-dibenzylamino)-1-(tert-butyldimethylsilyloxy)-5-heptadecanone 
• 366785-11-7 (4S,5R)-4-(N,N-dibenzylamino)-1-(tert-butyldimethylsilyloxy)-5-heptadecanol 
• 205068-02-6 (-)-S-5-(tert-butyldimethylsilyloxy)-2-(N,N-dibenzylamino)-1-pentanal 
• 15890-72-9 laurylmagnesium bromide 
• 366785-15-1 (4S,5R)-4-(N,N-dibenzylamino)-5-[(2-methoxyethoxy)methoxy]-1-heptadecanol 

Downstream Products

• 366785-17-3 (4S,5R)-4-(N,N-dibenzylamino)-5-[(2-methoxyethoxy)methoxy]heptadecanoic acid 

Relevant academic research and scientific papers

Stereoselective synthesis of (5S,6S)- and (5S,6R)-aza-muricatacin from an L-glutamic acid derivative

A stereodivergent synthesis of threo and erythro aza-muricatacin, a non-natural aza-analogue of the bioactive annonaceous acetogenin muricatacin, is presented. The configuration of the C(5) stereocenter is controlled by diastereoselective alkylation of α-